Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
伊沙妥昔单抗、来那度胺、地塞米松和硼替佐米联合治疗不适合移植的多发性骨髓瘤：随机3期BENEFIT试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-024-03050-2
Leleu, Xavier; Hulin, Cyrille; Lambert, Jerome; Bobin, Arthur; Perrot, Aurore; Karlin, Lionel; Roussel, Murielle; Montes, Lydia; Cherel, Brieuc; Chalopin, Thomas; Slama, Borhane; Chretien, Marie-Lorraine; Laribi, Kamel; Dingremont, Claire; Roul, Christophe; Mariette, Clara; Rigaudeau, Sophie; Calmettes, Claire; Dib, Mamoun; Tiab, Mourad; Vincent, Laure; Delaunay, Jacques; Santagostino, Alberto; Macro, Margaret; Bourgeois, Emmanuelle; Orsini-Piocelle, Frederique; Gay, Julie; Bareau, Benoit; Bigot, Noemie; Vergez, François; Lebreton, Pierre; Tabrizi, Reza; Waultier-Rascalou, Agathe; Frenzel, Laurent; Le Calloch, Ronan; Chalayer, Emilie; Braun, Thorsten; Lachenal, Florence; Corm, Selim; Kennel, Celine; Belkhir, Rakiba; Bladé, Jean-Sebastien; Joly, Bertrand; Richez-Olivier, Valentine; Gardeney, Helene; Demarquette, Helene; Robu-Cretu, Daniela; Garderet, Laurent; Newinger-Porte, Muriel; Kasmi, Amine; Royer, Bruno; Decaux, Olivier; Arnulf, Bertrand; Belhadj, Karim; Touzeau, Cyrille; Mohty, Mohamad; Manier, Salomon; Moreau, Philippe; Avet-Loiseau, Hervé; Corre, Jill; Facon, Thierry
